Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)

NCT04474223 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT04474223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04474223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
Lead sponsor
NYU Langone Health
Phase
Phase 3
Overall status
Active, not recruiting
Start date
August 1, 2020
Completion date
June 30, 2029
Enrollment
1,300 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

avb - atrioventricular block, fetal avb